Home Interviews What will Cereno Scientifics 250 MSK loan mean for the shareholders?

What will Cereno Scientifics 250 MSK loan mean for the shareholders?

What will Cereno Scientifics 250 MSK loan mean for the shareholders?

14 November, 2024

Following the company’s positive results from the phase II trial and pivot to fully focus on rare diseases, Cereno Scientific secured a substantial loan. Watch Sten R Sörensen, CEO talk about how this will influence the business and shareholders.

Watch the interview with CEO Sten R. Sörensen below:

YouTube video

The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.

Prenumerera på BioStocks nyhetsbrev

Share this!

RELATED ARTICLESMORE FROM AUTHOR